Almac and ESMS Global Collaborate on Emergency Unblinding

November 24, 2014

Applied Clinical Trials

Almac and ESMS have combined their expert knowledge to offer clients an exclusive solution surrounding emergency unblinding procedures.

Almac, a provider of advanced clinical technology and support services for the pharmaceutical and biotech industries, and ESMS, a 24/7 medical emergency response service for clinical trials have combined their expert knowledge to offer clients an exclusive solution surrounding emergency unblinding procedures.

In compliance with E6 Good Clinical Practice (GCP) regulations [section 5.13], this unique partnership provides clinical trial sponsors immediate access to the clinical assessment for and, if deemed appropriate, emergency unblinding procedures to support patient safety even if the Principal Investigator is not physically present with the patient. This service is designed to reduce time, effort and disturbance to the study subject involved to help patient retention and global capture of safety reports. This is achieved through Almac's IRT service with ESMS' emergency response service.

Read the full release here.

 

Related Content:

News